LATE METABOLIC ACIDOSIS OF NEWBORN

This adverse event was reported 24 times

These drugs are most commonly taken by patients reporting LATE METABOLIC ACIDOSIS OF NEWBORN:

# Drug Count
0 DICLOFENAC 4
1 DICLOFENAC SODIUM 4
2 VALPROATE SODIUM 4
3 LITHIUM 3
4 LITHIUM BROMATUM 3
5 QUETIAPINE 3
6 AMPICILLIN 2
7 AMPICILLIN INJECTION 2
8 AMPICILLIN SODIUM 2
9 ATRACURIUM BESYLATE 2
See all common drugs associated with LATE METABOLIC ACIDOSIS OF NEWBORN

LATE METABOLIC ACIDOSIS OF NEWBORN is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ATRACURIUM BESYLATE 2 0.0028
1 IBUPROFEN LYSINE 1 0.0018
2 PORACTANT ALFA 1 0.0014
3 OXYTOCIN 1 0.0003
4 AMPICILLIN INJECTION 2 0.0003
5 AMPICILLIN 2 0.0002
6 VALPROATE SODIUM 4 0.0002
7 LITHIUM 3 0.0001
8 MISOPROSTOL 1 0.0001
9 THEOPHYLLINE ANHYDROUS 1 0.0001
See all drugs enriched for association with LATE METABOLIC ACIDOSIS OF NEWBORN

LATE METABOLIC ACIDOSIS OF NEWBORN is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Surfactant [EPC] 1 0.0009
1 Oxytocic [EPC] 1 0.0003
2 Prostaglandin E1 Analog [EPC] 1 0.0001
3 Bile Acid [EPC] 1 0.0000
4 Methylxanthine [EPC] 1 0.0000
5 Serotonin-3 Receptor Antagonist [EPC] 2 0.0000
6 Topoisomerase Inhibitor [EPC] 1 0.0000
7 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
8 Azole Antifungal [EPC] 1 0.0000
9 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
See all drug classes enriched for association with LATE METABOLIC ACIDOSIS OF NEWBORN